Artificial Tears Solution/ Drops
NDC Package 50268-043-15
Package Information
Artificial Tears solution/ dropses is a medication used to relieve dry, irritated eyes. This formulation utilizes a solution/ drops delivery system. Marketed by Avpak, this product is identified by NDC 50268-043 and is authorized under FDA application M018.
Identification & Billing
- RxCUI: 900138 - dextran 70 0.1 % / glycerin 0.2 % / hypromellose 0.3 % Ophthalmic Solution
- RxCUI: 900138 - dextran 70 1 MG/ML / glycerin 2 MG/ML / hypromellose 3 MG/ML Ophthalmic Solution
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Glycerol - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Increased Intravascular Volume - [PE] (Physiologic Effect)
- Non-Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Plasma Volume Expander - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 50268 - Avpak
- 50268-043 - Artificial Tears
- 50268-043-15 - 15 mL in 1 BOTTLE
- 50268-043 - Artificial Tears
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 50268-043-15 identifies a specific commercial package of 15 ml in 1 bottle of Artificial Tears, a human over the counter drug labeled by Avpak. This solution/ drops is formulated for ophthalmic use and contains dextran 70; glycerin; hypromelloses as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Avpak on January 05, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to relieve dry, irritated eyes. Common causes for dry eyes include wind, sun, heating/air conditioning, computer use/reading, and certain medications. This product may contain 1 or more of the following ingredients: carboxymethylcellulose, dextran, glycerin, hypromellose, polyethylene glycol 400 (PEG 400), polysorbate, polyvinyl alcohol, povidone, or propylene glycol, among others. Eye lubricants keep the eye moist, help to protect the eye from injury and infection, and decrease symptoms of dry eyes such as burning, itching, and feeling as if something is in the eye.
How is this Avpak product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 50268004315. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 15 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.